definiens: shall mean all Information and Inventions developedby or at the request of, or in the possession or Control of, BZL or its Affiliates as of the EffectiveDate or at any time during the term of this Agreement relating to PSMA, Antibodies or theExploitation of Licensed Products or Diagnostic Products that are Confidential Information, butexcluding ( i ) any Information and Inventions to the extent covered or claimed by issued BZLPatents, and ( ii ) any Joint Know - How . BZL Know - How shall include all : ( a ) scientific datarelating to PSMA or Antibodies, including DNA and amino acid sequences of, the human tissueand / or cell type expression profile for, and existing and available models for pre - clinicalvalidation of antibody - based products against, PSMA, ( b ) biological, chemical, pharmacological, toxicological, pharmaceutical, physical and analytical, clinical, safety, manufacturing and qualitycontrol data and information related to Licensed Products or Diagnostic Products, ( c ) assays andbiological methodology necessary or useful for the Exploitation of Licensed Products orDiagnostic Products, and ( d ) any and all Information and Inventions developed in connectionwith or otherwise resulting from Development Activities performed by or on behalf of BZL thatis Confidential Information and is not covered or claimed by issued BZL Patents and is not JointKnow - How